ReviewFrontiers in cardiovascular medicine2026
The role of different types of programmed cell death in myocardial fibrosis: from mechanisms to therapeutics.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular diseases remain one of the leading causes of death in both developed and developing countries, imposing a substantial disease burden. Myocardial fibrosis-one of the most common pathological changes in the development of cardiovascular diseases-is characterized by excessive deposition of the extracellular matrix (ECM). Myocardial fibrosis can lead to impaired cardiac systolic and diastolic functions. Programmed cell death (PCD) plays an important role in the occurrence and development of myocardial fibrosis. Different types of PCD-such as apoptosis, autophagic programmed cell death, ferroptosis, necroptosis, and pyroptosis-affect the activation and proliferation of cardiac fibroblasts, as well as the synthesis and degradation of ECM through their unique signaling pathways. An in-depth understanding of the mechanisms of programmed cell death in myocardial fibrosis is expected to provide new targets and strategies for the treatment of cardiovascular diseases. Therefore, this article will systematically review the roles of different types of programmed cell death in myocardial fibrosis and explore potential treatment methods based on these mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.